Free Trial

Misonix (MSON) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
2 shs
Average Volume
60,302 shs
Market Capitalization
$462.06 million
P/E Ratio
Dividend Yield
Price Target
MSON stock logo

About Misonix Stock (NASDAQ:MSON)

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

MSON Stock News Headlines

See More Headlines
Receive MSON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Laboratory Apparatus & Furniture
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$74.02 million
Book Value
$7.77 per share


Free Float
Market Cap
$462.06 million
Not Optionable

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Stavros G. Vizirgianakis
    Chief Executive Officer & Director
  • Allan R. Staley
  • Sharon W. Klugewicz
    Chief Operating Officer
  • Joseph P. Dwyer
    Chief Financial Officer, Secretary & Treasurer
  • Daniel Voic
    VP-Engineering, Research & Development

MSON Stock Analysis - Frequently Asked Questions

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) issued its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative trailing twelve-month return on equity of 10.36% and a negative net margin of 19.55%.

What is Michael A. McManus Jr.'s approval rating as Misonix's CEO?

3 employees have rated Misonix Chief Executive Officer Michael A. McManus Jr. on Michael A. McManus Jr. has an approval rating of 33% among the company's employees. This puts Michael A. McManus Jr. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Misonix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Varian Medical Systems (VAR), Sociedad Química y Minera de Chile (SQM), Avadel Pharmaceuticals (AVDL), Second Sight Medical Products (EYES), Aldeyra Therapeutics (ALDX), Ardelyx (ARDX) and Athenex (ATNX).

This page (NASDAQ:MSON) was last updated on 5/27/2024 by Staff

From Our Partners